Zeronac-M is a powerful Cox-2 selective inhibitor designed for the management of pain, fever, and inflammation in animals. Containing Meloxicam (1.5mg/ml), this non-steroidal anti-inflammatory drug (NSAID) effectively reduces inflammation, joint pain, and fever by inhibiting the cyclooxygenase (COX) enzyme, which plays a key role in prostaglandin synthesis. Zeronac-M provides targeted relief for musculoskeletal disorders, pre-operative care, and fever-related discomfort. Available in both 15ml and 30ml bottles, Zeronac-M is a trusted choice for managing pain and inflammation in veterinary patients, promoting quicker recovery and improved quality of life.
Other musculoskeletal disorder
Fever & Pain
Pre Operative Care
The 15ml and 30ml variations of Zeronac-M provide flexibility in dosage and usage depending on the size and number of animals being treated. The 15ml bottle is ideal for smaller pets or short-term use, such as post-surgery recovery or minor injuries, while the 30ml bottle suits larger animals or longer-term treatment plans. Offering both options ensures that veterinarians can prescribe the appropriate quantity based on the animal's weight, condition, and duration of treatment. This variety helps minimize wastage and ensures that the treatment is both cost-effective and convenient for pet owners and clinics.
Zeronac-M contains Meloxicam, a selective COX-2 inhibitor that targets pain and inflammation at the source. COX-2 is an enzyme primarily involved in the production of pro-inflammatory molecules called prostaglandins. By inhibiting COX-2, Meloxicam effectively reduces the synthesis of these inflammatory mediators, providing relief from pain, swelling, and fever in musculoskeletal disorders and post-operative care. This selective inhibition reduces the risk of gastrointestinal side effects commonly seen with non-selective NSAIDs.
Meloxicam in Zeronac-M demonstrates powerful anti-inflammatory and analgesic effects, which are crucial in managing pain and inflammation associated with conditions such as arthritis, joint disorders, and musculoskeletal injuries. By decreasing inflammation, it alleviates discomfort and improves mobility, which enhances the quality of life in pets suffering from chronic or acute pain. Additionally, its anti-inflammatory properties make it effective for treating conditions like fever, thereby helping animals recover more comfortably.
Zeronac-M is highly effective in both pre-operative and post-operative care. Prior to surgery, it helps to reduce inflammation and pain, allowing for better overall management of the animal’s condition. Post-surgery, it speeds up recovery by controlling inflammation and reducing pain, helping the animal recover quickly and with minimal discomfort. Its use in pre- and post-operative settings ensures a smoother recovery process and prevents complications related to pain and inflammation after surgical procedures.
Q
What conditions can Zeronac-M help treat in animals?
A
Zeronac-M is effective in treating a variety of conditions involving pain and inflammation. It is commonly used to manage musculoskeletal disorders, such as arthritis, joint pain, and other inflammatory conditions. It is also beneficial for controlling post-operative pain, fever, and reducing inflammation due to injuries or surgical procedures.
Q
How should Zeronac-M be administered to pets?
A
Zeronac-M is typically administered as an oral suspension. The dosage depends on the weight of the animal and the condition being treated. It is important to follow the veterinarian's dosage recommendations. Typically, the suspension is given once a day or as prescribed by the vet to ensure optimal efficacy and safety.
Q
What makes Zeronac-M different from other pain relief medications for pets?
A
Zeronac-M stands out because it contains Meloxicam, a selective COX-2 inhibitor, which primarily targets the enzyme responsible for pain and inflammation without affecting COX-1, which helps protect the stomach lining. This selectivity reduces the risk of gastrointestinal side effects, making Zeronac-M a safer option for managing long-term pain in pets compared to non-selective NSAIDs.
